These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24847964)

  • 21. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
    Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
    Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
    Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M
    J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
    Oliveira AF; Silva GA; Almeida DM
    Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Radiation Therapy and Botulinum Toxin Injections in the Management of Sialorrhea in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review.
    Shehee L; O'Rourke A; Garand KL
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):205-221. PubMed ID: 32453096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.
    Stone CA; O'Leary N
    J Pain Symptom Manage; 2009 Feb; 37(2):246-58. PubMed ID: 18676117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of sialorrhea with botulinum toxin: an overview].
    Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
    Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study.
    Paracka L; Kollewe K; Klietz M; Petri S; Dressler D
    J Neural Transm (Vienna); 2019 Oct; 126(10):1341-1345. PubMed ID: 31317261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
    Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
    Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin A as treatment for drooling saliva in PD.
    Pal PK; Calne DB; Calne S; Tsui JK
    Neurology; 2000 Jan; 54(1):244-7. PubMed ID: 10636161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of sialorrhea in amyotrophic lateral sclerosis.
    Tysnes OB
    Acta Neurol Scand Suppl; 2008; 188():77-81. PubMed ID: 18439227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions.
    Singh H; Nene Y; Mehta TR; Govindarajan R
    Front Neurol; 2020; 11():513. PubMed ID: 32587569
    [No Abstract]   [Full Text] [Related]  

  • 35. Interventions for drooling in children with cerebral palsy.
    Walshe M; Smith M; Pennington L
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008624. PubMed ID: 23152263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound-guided botulinum toxin injections for treatment of drooling.
    Breheret R; Bizon A; Jeufroy C; Laccourreye L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis.
    Manrique D
    Braz J Otorhinolaryngol; 2005; 71(5):566-9. PubMed ID: 16612515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Experience of Treating Drooling with Repeated Botulinum Toxin Injections.
    Sillanpää S; Sipilä M; Numminen J; Rautiainen M
    ORL J Otorhinolaryngol Relat Spec; 2015; 77(6):333-8. PubMed ID: 26418063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative and quantitative scintigraphy in sialorrhea before and after botulinum toxin injection.
    Ribeiro LB; Xerez DR; Maliska C; de Souza SAL; Costa MMB
    Laryngoscope; 2019 Nov; 129(11):2521-2526. PubMed ID: 30693525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.